Skip to main content
Top
Published in: BMC Immunology 1/2019

Open Access 01-12-2019 | Human Immunodeficiency Virus | Research article

The predictive role of CD4+ cell count and CD4/CD8 ratio in immune reconstitution outcome among HIV/AIDS patients receiving antiretroviral therapy: an eight-year observation in China

Authors: Chong-Xi Li, Yu-Ye Li, Li-Ping He, Jing Kou, Jin-Song Bai, Jun Liu, Bo Tian, Li-Juan Cao, Kun-Hua Wang, Yi-Qun Kuang

Published in: BMC Immunology | Issue 1/2019

Login to get access

Abstract

Background

The immune reconstitution after initiation of highly active antiretroviral therapy (HAART) among HIV-infected individuals substantially affects patients’ prognosis. However, the dynamic characteristics and predictors of reconstitution outcome remain unclear.

Methods

In this study, the HIV/AIDS patients with sustained virological suppression (viral load < 50 copies/ml) after HAART were enrolled. The patients were subgrouped into immunological non-responders (INRs) (< 200 cells/μl), immunological inadequate responders (IIRs) (200 ~ 500 cells/μl) and immunological responders (IRs) (> 500 cells/μl) according to the CD4 cell count after two-year HAART. The immune reconstitution data based on the CD4+ and CD8+ cell counts with 8-year follow-up were collected for analysis.

Results

The CD4+ cell counts in the immunological responders (IRs) were significantly higher than in the immunological non-responders (INRs) and immunological inadequate responders (IIRs) (P <  0.001). The overall CD4+ cell count and CD4/CD8 ratio in the IRs increased faster than the IIRs and INRs. The CD4+ cell count growth at 0.5 year and 1 year after HAART in the IRs was significantly higher than the IIRs and INRs. The ROC curve demonstrated that 1 year CD4+ cell count had the highest predictive value, with the best cut-off value of 188 cells/μl, the predictive sensitivity was 81.0%, the predictive specificity was 85.2%, false positive rate was 14.8%, false negative rate was 19.0%, positive predictive value (IR) was 63.0%, negative predictive value (INR) was 93.5%.

Conclusions

Taken together, our findings suggest that early initiation of HAART can reduce the immune reconstitution failure. The combination of baseline CD4+ cell count and baseline CD4/CD8 ratio may serve as a valid predictor of immune reconstitution prognosis after HAART.
Appendix
Available only for authorised users
Literature
1.
go back to reference Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. The lancet HIV 2017. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. The lancet HIV 2017.
2.
go back to reference Pakker NG, Kroon ED, Roos MT, Otto SA, Hall D, Wit FW, Hamann D, van der Ende ME, Claessen FA, Kauffmann RH, et al. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group. AIDS. 1999;13(2):203–12.CrossRefPubMed Pakker NG, Kroon ED, Roos MT, Otto SA, Hall D, Wit FW, Hamann D, van der Ende ME, Claessen FA, Kauffmann RH, et al. Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group. AIDS. 1999;13(2):203–12.CrossRefPubMed
4.
go back to reference Saison J, Ferry T, Demaret J, Maucort-Boulch D, Venet F, Perpoint T, Ader F, Icard V, Chidiac C, Monneret G. Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia. J Int AIDS Soc. 2014;17(4 Suppl 3):19672.CrossRefPubMedPubMedCentral Saison J, Ferry T, Demaret J, Maucort-Boulch D, Venet F, Perpoint T, Ader F, Icard V, Chidiac C, Monneret G. Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia. J Int AIDS Soc. 2014;17(4 Suppl 3):19672.CrossRefPubMedPubMedCentral
9.
go back to reference Mussini C, Lorenzini P, Cozzi-Lepri A, Lapadula G, Marchetti G, Nicastri E, Cingolani A, Lichtner M, Antinori A, Gori A, et al. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. The lancet HIV. 2015;2(3):e98–106. https://doi.org/10.1016/S2352-3018(15)00006-5.CrossRefPubMed Mussini C, Lorenzini P, Cozzi-Lepri A, Lapadula G, Marchetti G, Nicastri E, Cingolani A, Lichtner M, Antinori A, Gori A, et al. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. The lancet HIV. 2015;2(3):e98–106. https://​doi.​org/​10.​1016/​S2352-3018(15)00006-5.CrossRefPubMed
10.
go back to reference Serrano-Villar S, Gutierrez C, Vallejo A, Hernandez-Novoa B, Diaz L, Abad Fernandez M, Madrid N, Dronda F, Zamora J, Munoz-Fernandez MA, et al. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. The Journal of infection. 2013;66(1):57–66. https://doi.org/10.1016/j.jinf.2012.09.013.CrossRefPubMed Serrano-Villar S, Gutierrez C, Vallejo A, Hernandez-Novoa B, Diaz L, Abad Fernandez M, Madrid N, Dronda F, Zamora J, Munoz-Fernandez MA, et al. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. The Journal of infection. 2013;66(1):57–66. https://​doi.​org/​10.​1016/​j.​jinf.​2012.​09.​013.CrossRefPubMed
11.
go back to reference Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, et al. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. The lancet HIV. 2017;4(6):e251–9. https://doi.org/10.1016/S2352-3018(17)30043-7.CrossRefPubMed Caniglia EC, Cain LE, Sabin CA, Robins JM, Logan R, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, et al. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. The lancet HIV. 2017;4(6):e251–9. https://​doi.​org/​10.​1016/​S2352-3018(17)30043-7.CrossRefPubMed
12.
go back to reference Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;44(3):441–6. https://doi.org/10.1086/510746.CrossRef Moore RD, Keruly JC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;44(3):441–6. https://​doi.​org/​10.​1086/​510746.CrossRef
17.
go back to reference Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, et al. Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course. J Antimicrob Chemother. 2017;72(1):240–5.CrossRefPubMed Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, et al. Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course. J Antimicrob Chemother. 2017;72(1):240–5.CrossRefPubMed
20.
go back to reference Engsig FN, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Roge B, Jensen J, Nielsen LN, Obel N. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC Infect Dis. 2010;10:318.CrossRefPubMedPubMedCentral Engsig FN, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Roge B, Jensen J, Nielsen LN, Obel N. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study. BMC Infect Dis. 2010;10:318.CrossRefPubMedPubMedCentral
Metadata
Title
The predictive role of CD4+ cell count and CD4/CD8 ratio in immune reconstitution outcome among HIV/AIDS patients receiving antiretroviral therapy: an eight-year observation in China
Authors
Chong-Xi Li
Yu-Ye Li
Li-Ping He
Jing Kou
Jin-Song Bai
Jun Liu
Bo Tian
Li-Juan Cao
Kun-Hua Wang
Yi-Qun Kuang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2019
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/s12865-019-0311-2

Other articles of this Issue 1/2019

BMC Immunology 1/2019 Go to the issue